Newsbenzinga
These Analysts Cut Their Forecasts On Johnson & Johnson After Q3 Results
· Published
Article summary
Johnson & Johnson beat Q3 estimates and raised full-year guidance; sales rose 5.9%, EPS fell 7.5%. Analysts trimmed price targets.
An excerpt from the original article.
Comments —
Loading comments…